| 上海复宏汉霖生物技术股份有限公司-H股, 02696.HK - 公司概览 |
| 集团主席 |
Wenjie Zhang |
| 发行股本(股) |
163,000,000 |
| 面值币种 |
人民币 |
| 股票面值 |
1.0 |
| 行业分类 |
生物技术 |
| 公司业务 |
集团主要从事(i)单克隆抗体(mAb)药物的研发、生产、销售及提供相关技术服务（除人类干细胞、基因诊断与治疗技术的开发和应用）及(ii)转让自有技术及提供相关技术咨询服务。 |
资料来源于上市公司财务报表
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window